scholarly journals Parapharyngeal lipoma mimicking parotid tumour in a 4-year-old boy

2021 ◽  
Vol 17 (1) ◽  
pp. 72-76
Author(s):  
Siti Nazira Abdullah ◽  
◽  
Juani Hayyan Abdul Karaf ◽  
Vijayaprakash Rao A/L Ramanna ◽  
Najah Momin ◽  
...  

Parapharyngeal space tumour is rare in paediatrics. It can either be a primary tumour arising from parapharyngeal space structures, an extension from the surrounding structures or a metastatic tumour. In adults, salivary gland tumours and paragangliomas are common, while neurogenic tumours predominate in paediatrics. The delicate anatomy in the parapharyngeal space makes the diagnostic procedures more complex, especially in paediatrics. Although tissue biopsy can be obtained under sedation or local anaesthesia, it is histologically difficult to differentiate lipoma from liposarcoma. We present a paediatric case with a large parapharyngeal space mass in a 4-year-old boy and the management used.

2018 ◽  
Vol 21 (2) ◽  
pp. 186-194
Author(s):  
Laura Blackwood ◽  
Aaron Harper ◽  
James Elliott ◽  
Irina Gramer

Case series summary Salivary gland carcinoma is uncommon in cats. We report the outcome of radiation therapy in six cases (four salivary gland adenocarcinomas, one tubulopapillary adenocarcinoma, one carcinoma). Five were treated after surgical excision of the primary tumour, but four had gross disease (primary or metastatic) at the time of starting radiotherapy. Exact progression-free interval from the start of radiotherapy in the two cats where this was known was 120 and 144 days, respectively. One cat was signed off at 766 days with no evidence of recurrence. Another cat was in remission at 202 days (when last seen by the referring practice) but subsequently developed recurrence (date uncertain). Survival time was known for three cats (55 days, 258 days and 570 days from initiation of radiotherapy, respectively). In two cases, locoregional progressive disease (PD) was confirmed, and the other presumed as the cause of death. Two cats, known to have developed PD, were alive at the time of writing (at 206 and 549 days, respectively). No cat died as a result of distant metastatic disease. Relevance and novel information There is a paucity of information on the treatment of salivary gland tumours. In humans, as in cats, there is no optimised standard of care for malignant tumours. It is accepted that, for surgical candidates (even with large tumours), surgery and radiotherapy is superior to radiotherapy alone. However, the benefits of postoperative radiotherapy compared with surgery alone are only clear in patients with high-risk tumours (ie, those with large and invasive primary tumours, close or incomplete margins, high histopathological grade, histological evidence of neural or vascular invasion, or positive lymph nodes). This population is analogous to the population reported here, and likely to most cats presented in practice. Thus, radiation therapy may help improve locoregional control and survival in cats.


1991 ◽  
Vol 105 (9) ◽  
pp. 780-781 ◽  
Author(s):  
M. K. George ◽  
Paul Mansour ◽  
A. L. Pahor

AbstractTerminal duct carcinoma of salivary glands is an uncommon, histologically distinctive, low grade malignant neoplasm arising from the intercalated salivary duct. We present a case arising eight years after removal of a parotid tumour reported as a pleomorphic adenoma. We describe the clinico-pathological features of the present tumour, illustrate the difficulties that may be encountered in differentiating it from other salivary gland tumours, and discuss the possible significance of the previous tumour.


2015 ◽  
Vol 129 (11) ◽  
pp. 1140-1142
Author(s):  
C Mukherjee ◽  
A Sadiq ◽  
P Mehta ◽  
H Ahluwalia

AbstractObjective:To report three cases illustrating that it is not unusual for a primary eyelid tumour to metastasise to the parotid gland and vice versa.Case reports:Two patients with malignant parotid tumours underwent radical parotidectomy and presented subsequently with eyelid lesions. Biopsy showed that both eyelid lesions were histologically similar to the primary parotid tumour. A third patient was noted to have ipsilateral upper eyelid and parotid gland tumours. Histology and immunocytochemistry were used to differentiate the primary tumour and the metastasis.Conclusion:These cases illustrate that tumours involving eyelids and parotid glands can present simultaneously or sequentially, and either of these structures could be the focus of primary or metastatic tumour. The important message for oculoplastic and parotid surgeons is to routinely assess both the periocular and parotid area when patients present with a mass in either structure.


2015 ◽  
Vol 76 (S 01) ◽  
Author(s):  
Christopher Rassekh ◽  
Gregory Weinstein ◽  
Laurie Loevner ◽  
Ara Chalian ◽  
Bert O'Malley

1999 ◽  
Vol 8 (3) ◽  
pp. 201-212
Author(s):  
Mohi Al-Tamami ◽  
Nail Al-Naqeeb ◽  
Agnes Kovacs ◽  
Hussein Dashti ◽  
John Madda Patrick

Author(s):  
Edward Balai ◽  
Navdeep Bhamra ◽  
Karan Jolly

Salivary gland tumours are uncommon and account for just 6% of all head and neck neoplasms. Worldwide incidence varies, from 0.4 to 13.5 cases per 100 000 population. The parotid gland is by far the most commonly affected site, accounting for 80% of cases. The vast majority of these tumours are benign; only approximately 20–25% being malignant. This article considers the relevant clinical anatomy of the parotid gland, key aspects of assessment with history and examination, and when to refer to secondary care for further investigation. It will touch on the common benign and malignant parotid neoplasms and give an overview of secondary care management.


Sign in / Sign up

Export Citation Format

Share Document